Literature DB >> 9278514

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

K Paech1, P Webb, G G Kuiper, S Nilsson, J Gustafsson, P J Kushner, T S Scanlan.   

Abstract

The transactivation properties of the two estrogen receptors, ERalpha and ERbeta, were examined with different ligands in the context of an estrogen response element and an AP1 element. ERalpha and ERbeta were shown to signal in opposite ways when complexed with the natural hormone estradiol from an AP1 site: with ERalpha, 17beta-estradiol activated transcription, whereas with ERbeta, 17beta-estradiol inhibited transcription. Moreover, the antiestrogens tamoxifen, raloxifene, and Imperial Chemical Industries 164384 were potent transcriptional activators with ERbeta at an AP1 site. Thus, the two ERs signal in different ways depending on ligand and response element. This suggests that ERalpha and ERbeta may play different roles in gene regulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278514     DOI: 10.1126/science.277.5331.1508

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  437 in total

Review 1.  Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse.

Authors:  J L Fendrick; A M Raafat; S Z Haslam
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 2.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 3.  Estrogen receptor and the SERM concept.

Authors:  G G Kuiper; G J van den Bemd; J P van Leeuwen
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

4.  Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex.

Authors:  G B Tremblay; A Tremblay; F Labrie; V Giguère
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 5.  Estrogen receptors: orchestrators of pleiotropic cellular responses.

Authors:  J G Moggs; G Orphanides
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

Review 6.  Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

Authors:  S Signoretti; M Loda
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

7.  Distinct expression patterns of ER alpha and ER beta in normal human mammary gland.

Authors:  V Speirs; G P Skliris; S E Burdall; P J Carder
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

8.  Presence of oestrogen receptor type beta in human retina.

Authors:  C Munaut; V Lambert; A Noël; F Frankenne; M Deprez; J M Foidart; J M Rakic
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

9.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

Review 10.  Structural and functional characteristics of oestrogen receptor β splice variants: Implications for the ageing brain.

Authors:  C K Kim; A Torcaso; A Asimes; W C J Chung; T R Pak
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.